We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CTE market cap is 38.8M. The company's latest EPS is AUD 0.0289 and P/E is 27.34.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 7.91M | 9.93M | 10.07M | 11.76M | 11.94M |
| Operating Income | -19k | 1.72M | 1.11M | 1.89M | 1.52M |
| Net Income | -1.72M | 1.48M | 653k | 1.36M | 1.41M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 23.17M | 23.5M | 21.99M | 21.5M | 22.65M |
| Total Liabilities | 24.89M | 23.79M | 21.62M | 19.64M | 19.87M |
| Total Equity | -1.72M | -287k | 378k | 1.86M | 2.78M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -648k | 1.28M | 488k | 2.52M | 1.41M |
| Investing | 32k | -882k | -374k | -860k | -1.22M |
| Financing | N/A | -255k | -295k | -180k | -796k |
| Market Cap | 38.8M |
| Price to Earnings Ratio | 27.34 |
| Price to Sales Ratio | 3.23 |
| Price to Cash Ratio | 8.15 |
| Price to Book Ratio | 13.86 |
| Dividend Yield | - |
| Shares Outstanding | 48.81M |
| Average Volume (1 week) | 14.66k |
| Average Volume (1 Month) | 12.08k |
| 52 Week Change | 8.90% |
| 52 Week High | 0.84 |
| 52 Week Low | 0.505 |
| Spread (Intraday) | 0.01 (0.63%) |
| Company Name | Cryosite Limited |
| Address |
13a ferndell street, south granville sydney, new south wales 2142 |
| Website | https://www.cryosite.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
